System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ppublish 1 citation

PubMed: 40116505 DOI: 10.1128/jvi.01989-24

Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.

J Virol 99(4):e0198924

Authors: Ashley C Beavis, Zhuo Li, Kelsey Briggs, MarĂ­a Cristina Gingerich, Elizabeth R Wrobel, Maria Najera, Dong An, Nichole Orr-Burks, Jackelyn Murray, Preetish Patil, Jiachen Huang, Jarrod Mousa, Linhui Hao, Tien-Ying Hsiang, Michael Gale, Stephen B Harvey, S Mark Tompkins, Robert Jeffrey Hogan, Eric R Lafontaine, Hong Jin, Biao He

Affiliations

  • CyanVac LLC, Athens, Georgia, USA.
  • Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
  • Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, USA.
  • Animal Resources, University of Georgia, Athens, Georgia, USA.
  • Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.

MeSH

Sars-Cov-2, Vaccines, Covid-19 Vaccines, Covid-19, Viruses, Parainfluenza Virus 5, Severe Acute Respiratory Syndrome-Related Coronavirus

Cited by